Stay updated on Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.
Latest updates to the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.3 appears in the page footer, replacing the previous Revision: v3.5.2. This reflects a minor maintenance update that does not alter study information.SummaryDifference0.0%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible changes to the study details content.SummaryDifference0.0%
- Check32 days agoChange DetectedMantova, Italy has been replaced with Mantua, Italy in the locations list. The city name is updated to its common English form to improve clarity for participants and searchability.SummaryDifference0.0%
- Check39 days agoChange DetectedAdded Severe myoclonic epilepsy in infancy as a related topic and introduced a Genetic and Rare Diseases Information Center resource in the Resources section.SummaryDifference0.1%
- Check47 days agoChange DetectedRemoved the study's condition label 'Dravet syndrome' and the Genetic and Rare Diseases Information Center resource from the page.SummaryDifference0.1%
- Check54 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%
Stay in the know with updates to Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Dravet Syndrome Clinical Trial page.